y0news
AnalyticsDigestsSourcesTopicsRSSAICrypto

#rare-disease-diagnosis News & Analysis

4 articles tagged with #rare-disease-diagnosis. AI-curated summaries with sentiment analysis and key takeaways from 50+ sources.

4 articles
AIBullishOpenAI News · Jun 187/10
🧠

Using AI to help physicians diagnose rare genetic diseases affecting children

Researchers leveraged an OpenAI reasoning model to diagnose rare genetic diseases in children, successfully identifying 18 new diagnoses in previously unsolved cases. This breakthrough demonstrates AI's potential to accelerate medical diagnosis and improve outcomes for patients with rare conditions that traditionally take years to identify.

🏢 OpenAI
AIBullisharXiv – CS AI · May 97/10
🧠

A Versatile AI Agent for Rare Disease Diagnosis and Risk Gene Prioritization

Researchers introduced Hygieia, an AI agent system that integrates phenotypic, genetic, and clinical data to diagnose rare diseases and prioritize risk genes. Validated with clinical experts from Yale and Duke-NUS, the system demonstrated 12-60% diagnostic accuracy improvements over physicians and reduced clinician workload in real-world applications.

AIBullishOpenAI News · May 296/10
🧠

Boston Children’s uses AI to unlock new diagnoses

Boston Children's Hospital deployed OpenAI technology to improve diagnostic accuracy for rare diseases, successfully identifying over 40 previously undiagnosed cases while reducing operational strain. This application demonstrates AI's expanding role in healthcare beyond administrative tasks, directly impacting patient outcomes in complex medical scenarios.

🏢 OpenAI
AINeutralarXiv – CS AI · May 126/10
🧠

Shapley Regression for Rare Disease Diagnosis Support: a case study on APDS

Researchers propose Shapley regression, a game-theoretic machine learning method for diagnosing APDS, a rare genetic immune disorder. The approach combines interpretability with predictive power by modeling symptom interactions while maintaining transparency, validated on both public datasets and a real-world cohort of 222 patients.